An 18-year-old young male presented with a reddish lesion in his left eye since birth. On examination, tortuous vascular lesions on the temporal and inferior bulbar conjunctiva were seen \[[Fig. 1a](#F1){ref-type="fig"}\]. Rest of the ocular and systemic examination was within normal limits. The patient underwent excision of the lesion. Scleral thinning was noted underneath the lesion. Histopathological examination was consistent with the diagnosis of cavernous hemangioma of the conjunctiva \[[Fig. 1b](#F1){ref-type="fig"}\]. Postoperative period was uneventful \[[Fig. 1c](#F1){ref-type="fig"}\].

![(a) Clinical photograph of left eye of the patient showing tortuous elevated dark-red vascular lesions on the temporal conjunctiva measuring 10 × 8 × 2 mm in size and another lesion in the inferior bulbar conjunctiva measuring 2 × 4 × 1 mm. (b) Microphotograph showing conjunctival stroma with multiple large vascular spaces filled with blood. (Hematoxylin and eosin stain; 40×). (c) Postoperative appearance of the left eye](IJO-67-2061-g001){#F1}

Cavernous hemangiomas of the conjunctiva have rarely been reported in the literature.\[[@ref1][@ref2][@ref3][@ref4]\] The other common vascular tumors of the conjunctiva in the pediatric age group are capillary hemangioma, lymphangioma, and pyogenic granuloma.\[[@ref5]\] Complete resolution has been noted after topical timolol therapy.\[[@ref6]\] We excised the lesion because of cosmetic concerns.
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